Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. on July 10, 2017. The report addresses a specific corporate event regarding the company's listing status on The NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes
On July 10, 2017, Trovagene, Inc. received notice from The NASDAQ Stock Market LLC indicating that the Company has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the context of the listing compliance event. The primary contingency addressed was the risk of delisting due to non-compliance with the minimum bid price, which has now been resolved.
Investor Verification Checklist
- Verify the current stock price to ensure continued compliance with NASDAQ minimum bid requirements.
- Review the press release furnished as Exhibit 99.1 for additional details on the compliance timeline.
- Confirm the company's status on the NASDAQ Capital Market via the exchange's official website.